MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$10,619K
EPS
-$0.95
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
License revenue
-200* -
Research and development
5,961 -18,749* 15,558
General and administrative
6,118 -12,382* 11,036
Total operating expenses
12,079 -31,131* 26,594
Gain from operations
-12,079 31,331* -26,594
Interest income (expense)
1,129 2,323* -96
Other income (expense), net
341 -4,794* 1,837
Total other income (expense), net
1,470 -2,471* 1,741
Gain before income taxes
-10,609 28,860* -24,853
Income tax expense
10 -128* -74
Net gain
-10,619 28,988* -24,779
Accretion of redeemable convertible preferred shares
-4,508* 846
Net gain attributable to common stockholders
-10,619 24,480 -25,625
Basic EPS
-0.95 20.148 -2.91
Diluted EPS
-0.95 20.148 -2.91
Basic Average Shares
11,211,268 1,215,031 8,526,781
Diluted Average Shares
11,211,268 1,215,031 8,526,781
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net gainattributable to common...-$10,619K Net gain-$10,619K Interest income(expense)$1,129K Other income(expense), net$341K Gain before incometaxes-$10,609K Income tax expense$10K Total other income(expense), net$1,470K Gain from operations-$12,079K Total operatingexpenses$12,079K General andadministrative$6,118K Research and development$5,961K

ImageneBio, Inc. (IMA)

ImageneBio, Inc. (IMA)